The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
The embody project by Enrico Glerean is hosted on Aalto University's GitLab platform, focusing on the development and management of related software and research projects. It covers research and development work in multiple fields.
The Department of Psychology, established in 1967, is an intellectually diverse community of scholars engaged in research addressing psychology at the levels of mind, brain, and society. We strive for excellence in our scholarship and teaching, and we seek to cultivate in our students a dedication to the highest standards in their endeavors. We are committed to collaboration within and across disciplinary boundaries, and to sustaining professional links with relevant local, national, and global organizations.
MedSci.cn provides medical calculation formulas and tools to help doctors and researchers conduct clinical and scientific research.